Bruker Corporation BRKR launched the new MALDI Biotyper sirius system for all previously FDA-approved assays and research-use-only (RUO) MALDI Biotyper (MBT) reference libraries at the ASM Microbe ...
MONTREAL--(BUSINESS WIRE)-- At the 2011 Annual Meeting of the Canadian Association for Clinical Microbiology and Infectious Diseases (CACMID), the companies i2A Canada and Bruker Ltd. announced ...
Bruker Corporation BRKR recently announced a collaboration and quality agreement with the medical device company, Accelerate Diagnostics Inc. AXDX. The agreement enables the validation of Bruker’s ...
Bruker is pleased to announce that AOAC International has approved the MALDI Biotyper solution for two new Official Methods of Analysis (OMA) for the confirmation and identification of pathogenic and ...
VIENNA--(BUSINESS WIRE)-- Prior to the 20 th Annual Meeting of the European Society of Clinical Microbiology and Infectious Diseases on April 10-13, 2010 in Vienna, Bruker Daltonics and KIESTRA Lab ...
Two applications on the MALDI Biotyper were recently recognized and published as Official Methods of Analysis (OMA) of AOAC INTERNATIONAL for selected pathogens confirmation and identification of ...
SAN FRANCISCO, June 20, 2019 /PRNewswire/ -- At the ASM Microbe Conference 2019 (www.asm.org), Bruker launches the new MALDI Biotyper sirius system for all previously FDA-cleared, and for all research ...
Dr. Anne-Marie Fahr, Head of Microbiology at Labor Limbach, commented: "In contrast to previous introductions of other technologies, in the case of the MALDI Biotyper we have seen a very wide ...
Bruker's Biotyper enables molecular identification and taxonomical classification of bacteria, yeasts and fungi reliably and quickly using proteomic fingerprinting by high-throughput MALDI-TOF mass ...
Bruker Corporation BRKR launched the new MALDI Biotyper sirius system for all previously FDA-approved assays and research-use-only (RUO) MALDI Biotyper (MBT) reference libraries at the ASM Microbe ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results